Tripathi Suchi, Tripathi K
Institute of Medical Sciences, Banaras Hindu University, Varanasi.
J Indian Med Assoc. 2003 Apr;101(4):260-2, 264-5.
Renin angiotensin system in the genesis of hypertension was established long after Goldblatt's belief that the minute capillaries of the kidney regulate blood pressure and he also suggested kidney released a pressure substance which lead to rise of blood pressure. Guyton provided experimental and analytical data supporting the role of renal pressure natriuresis in the regulation of normal circulation and its function resulting in the pathogenesis of hypertension. Hady and Overbeck proposed that the blood pressure of volume expanded hypertension was raised by a circulating inhibitor of the Na+/K+ ATPase pump. Brenner et al proposed that hypertension may arise from a congenital reduction in the number of nephrons or in the filtration surface area per glomerulus, thereby limiting ability to excrete sodium, raising blood pressure. Renin angiotensin system can be interrupted at four sites by adrenergic blocker, renin inhibitor, angiotensin converting enzyme inhibitor and angiotensin receptor blocker. Non-modulation in the face of relatively high dietary sodium could explain the pathogenesis of sodium sensitive hypertension and provide a more targeted, rational therapy for its correction.
肾素-血管紧张素系统在高血压发病机制中的作用在戈德布拉特提出肾脏的微小毛细血管调节血压这一观点很久之后才得以确立,他还提出肾脏释放一种导致血压升高的加压物质。盖顿提供了实验和分析数据,支持肾压力性利钠在正常循环调节中的作用及其在高血压发病机制中的功能。哈迪和奥弗贝克提出,容量扩张性高血压的血压升高是由一种循环的钠钾ATP酶泵抑制剂引起的。布伦纳等人提出,高血压可能源于先天性肾单位数量减少或每个肾小球滤过表面积减少,从而限制了排钠能力,导致血压升高。肾素-血管紧张素系统可被肾上腺素能阻滞剂、肾素抑制剂、血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在四个部位阻断。面对相对高钠饮食时的非调节状态可以解释钠敏感性高血压的发病机制,并为其纠正提供更有针对性、更合理的治疗方法。